Nearly 100 GATA2 mutations have been described, either as germ-line genetic defects or somatic mutations in association with other drivers, such as biallelic CEBPA mutation in AML (Fig2, Tables I and SI). This evidence concerns the gene CEBPA and acute myeloid leukemia.